Merck & Co., Inc. (MRK)
150.33
-2.01
(-1.32%)
USD |
NYSE |
Sep 04, 16:00
150.51
+0.18
(+0.12%)
After-Hours: 20:00
Merck Market Cap : 371.11B for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 371.11B |
| September 03, 2026 | 376.07B |
| September 02, 2026 | 374.35B |
| September 01, 2026 | 369.95B |
| August 31, 2026 | 364.77B |
| August 28, 2026 | 366.22B |
| August 27, 2026 | 369.16B |
| August 26, 2026 | 377.95B |
| August 25, 2026 | 386.22B |
| August 24, 2026 | 371.93B |
| August 21, 2026 | 376.59B |
| August 20, 2026 | 367.80B |
| August 19, 2026 | 375.73B |
| August 18, 2026 | 333.69B |
| August 17, 2026 | 335.66B |
| August 14, 2026 | 335.34B |
| August 13, 2026 | 334.62B |
| August 12, 2026 | 328.13B |
| August 11, 2026 | 321.96B |
| August 10, 2026 | 323.19B |
| August 07, 2026 | 317.42B |
| August 06, 2026 | 316.90B |
| August 05, 2026 | 316.80B |
| August 04, 2026 | 316.12B |
| August 03, 2026 | 315.55B |
| Date | Value |
|---|---|
| July 31, 2026 | 321.55B |
| July 30, 2026 | 320.54B |
| July 29, 2026 | 321.95B |
| July 28, 2026 | 325.55B |
| July 27, 2026 | 322.94B |
| July 24, 2026 | 323.70B |
| July 23, 2026 | 322.25B |
| July 22, 2026 | 314.81B |
| July 21, 2026 | 311.82B |
| July 20, 2026 | 307.23B |
| July 17, 2026 | 314.89B |
| July 16, 2026 | 315.21B |
| July 15, 2026 | 305.28B |
| July 14, 2026 | 298.29B |
| July 13, 2026 | 306.32B |
| July 10, 2026 | 305.11B |
| July 09, 2026 | 308.88B |
| July 08, 2026 | 311.16B |
| July 07, 2026 | 318.24B |
| July 06, 2026 | 313.11B |
| July 02, 2026 | 319.97B |
| July 01, 2026 | 309.63B |
| June 30, 2026 | 317.36B |
| June 29, 2026 | 319.53B |
| June 26, 2026 | 317.75B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 662.82B |
| Eli Lilly & Co. | 1.082T |
| Pfizer Inc. | 162.14B |
| Bristol Myers Squibb Co. | 136.51B |
| Abbott Laboratories | 187.45B |
Market Cap Related Metrics
| PE Ratio | 120.16 |
| PS Ratio | 5.629 |
| Price to Book Value | 8.850 |
| Price to Free Cash Flow | 23.23 |
| Price | 150.33 |
| Earnings Yield | 0.83% |
| Operating PE Ratio | 29.93 |
| Normalized PE Ratio | 49.70 |